MML@IISER Tirupati
Molecular Microbiology Laboratory I Indian Institute of Science Education and Research, Tirupati
SELECT PUBLICATIONS
From IISER-Tirupati
Palande A, Patil S, Veeram A, Sahoo S S, Lodhiya T, Maurya P, M Balaji, Chugh J, Mukherjee R* (2024)
Proteomic analysis of the Mycobacterium tuberculosis outer membrane for potential implications in uptake of small molecules, ACS Infectious Diseases, In Press
Desai A, Mahajan V, Ramabhadran R* & Mukherjee R* (2024) Binding order of substrate and cofactor in sulfonamide monooxygenase during sulfa drug degradation: in silico studies, J Biomol Str and Dyn, In Press. DOI: 10.1080/07391102.2024.2306495
D Balasubramanian, R Mukherjee* (2023) Vaccine development: perspectives from life-history traits, Current Science, 124 (9), 1039
George E, Goswami, A, Lodhiya T, et al., (2022)
Immunomodulatory effect of mycobacterial outer membrane vesicles coated nanoparticles, Biomat Adv, 213003, DOI: 10.1016/j.bioadv.2022.213003.
(In collaboration with Rachit Agarwal, IISc Bengaluru)
Agrawal A, Gopu M, Mukherjee R*, and Mampallil D* (2022) Microfluidic Droplet Cluster with Distributed Evaporation Rates as a Model for Bioaerosols. Langmuir DOI: 10.1021/acs.langmuir.1c03273
(In collaboration with Dileep Mampallil, IISER Tirupati)
Lodhiya T, Devassy D and Mukherjee R*. "Parasite Proteomics." chapter in the "Textbook of parasitic zoonoses" Editor: S C Parija, Spinger Publishing, 2022. (In press)
Raju Mukherjee*, Rohit Satardekar (2021) Why are some coronavirus variants more infectious? J Biosci 46 (4), 1-10.
Agrawal A, Sinha S, Mukherjee R and Mampallil D* (2020) Dynamics of Bacterial Deposition in Evaporating Drops. Physics of Fluids 32, 093308. (In collaboration with Dileep Mampallil, IISER Tirupati)
Patil S, Palande A, Lodhiya T, Pandit A and Mukherjee R* (2020) Redefining genetic essentiality in Mycobacterium tuberculosis. Gene 765, 145091.
Mukherjee R (2020) Global efforts on vaccines for COVID-19: Since, sooner or later, we all will catch the coronavirus. J Biosci. ;45(1):68.
Saha D and Mukherjee R*. (2019) Ameliorating the antimicrobial resistance crisis: phage therapy. IUBMB Life 71(7):781-790
Raghavendra T, Patil S & Mukherjee R*. (2018)
Peptidoglycan in Mycobacteria: chemistry, biology and intervention. Glycoconjugate J 35(5):421-432.
Bharati Binod K, Mukherjee R & Chatterji D* (2018)
Substrate-induced domain movement in a bifunctional protein DcpA regulates cyclic‑di‑GMP turnover: Functional implications of a highly conserved motif. J Biol Chem 293(36):14065-14079.
Mukherjee R*, Chandrapal A & Banerjee M. (2017)
Enabling faster Go/No-Go decisions through secondary screens in anti-mycobacterial drug discovery. Tuberculosis, 106, 44-52.
Before joining IISER Tirupati:
Majumdar G., Mbau R., Singh V., Warner D F, Dragset M. & Mukherjee, R*.(2016) Genome-wide transposon mutagenesis in Mycobacterium tuberculosis and Mycobacterium smegmatis. Book chapter in “In Vitro Mutagenesis: Methods and Protocols”. Methods in Mol. Biol., 1498. 321-335. [ISBN 978-1-4939-6470-3]
Sommer R, Neres J, Piton J, Dhar N, van der Sar A, Mukherjee R, Laroche T, Dyson PJ, McKinney JD, Bitter W, Makarov V, Cole ST (2018) Fluorescent benzothiazinone analogs efficiently and selectively label DprE1 in mycobacteria and actinobacteria. ACS Chem. Biol., doi: 10.1021/acschembio.8b00790
Brecik, M., Centárová, I., Mukherjee, R., Kolly, G S. Huszár, S., Bobovska, A., Kilacsková, E., Mokošová, V., Svetlikova, Z., Šarkan, M., Neres, J., Korduláková, J., Cole, ST. & K. Mikušová. (2015) DprE1 is a vulnerable tuberculosis drug target due to its cell wall localization. ACS Chem. Biol., 10(7):1631-6.
Singh, V., Brecik, M., Mukherjee, R., Evans, J C., Svetlíková, Z., Blackburn, J., Warner, DF., Mikušová, K. & Mizrahi, V. (2015) The Complex Mechanism of Antimycobacterial Action of 5-Fluorouracil. Cell Chem. Biol., 22(1):63-75.
Hartkoorn, R. C., Sala, C., Neres, J., Pojer, F., Magnet, S. J., Mukherjee, R., Uplekar, S., Boy, S., Altmann K-H & Cole, S. T. (2012) Pyridomycin – Nature’s Isoniazid. EMBO Mol. Med., 10:1032-1042.
Mukherjee R*, Chatterji D. (2012) Glycopeptidolipids: immuno-modulators in greasy mycobacterial cell envelope. IUBMB Life, 64(3):215-25.
Vats A, Singh AK, Mukherjee R, Chopra T, Ravindran MS, Mohanty D, Chatterji D, Reyrat JM & Gokhale R. S. (2012) Retrobiosynthetic approach delineates the biosynthetic pathway and the structure of the acyl chain of mycobacterial glycopeptidolipids. J Biol Chem., 287 (36) : 30677-87.
Mukherjee, R.*, Adhikary,L., Khedkar, A & Iyer, H. (2010). Probing Deamidation in Therapeutic Immunoglobulin Gamma (IgG1) by Electron Transfer Dissociation Mass Spectrometry. Rapid Commun Mass Spectrum, 24, 879 – 884.
Mukherjee, R. & Chatterji, D. (2008). Stationary phase induced alterations in mycobacterial RNA polymerase assembly: A cue to its phenotypic resistance towards rifampicin. Biochem. Biophys. Res. Common., 369, 899-904.
Mukherjee, R. & Chatterji, D. (2008). Proteomics and mass spectrometric studies reveal planktonic growth of Mycobacterium smegmatis in biofilm cultures in the absence of rpoZ. Journal of Chromatography-B, 861,196-202